Durbin has been running Early Access Programmes for pharmaceutical and biotech companies on an exclusive basis for over 20 years.

We have extensive knowledge of the regulatory requirements in the EMEA markets and rest of the world. Having run these programmes both on a compassionate and named-patient basis, we offer excellent global distribution capabilities backed up by comprehensive reporting. For complete peace of mind, our experts can also provide a consultancy and pharmacovigilance service.

For further information please contact Bashir Parkar:

Tel: +44 (0)20 8869 6515
Mob: +44 (0)7971 034356
Fax: +44 (0)20 8869 6514
Email: b.parkar@durbin.co.uk